Physician

Keri Lynn Ingrassia-Squiers, DO

According to 2025 Medicare claims, Keri Ingrassia-Squiers, DO (NPI: 1467465203) practices internal medicine in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is PRIMARY CARE PARTNERS LLC (NPI: 1083900526; TIN: 274980253) and primary practice location at 07840-4227. Ingrassia-Squiers is affiliated with the Atlantic ACO (ACO ID: A1026), participating under the MSSP model.

Ingrassia-Squiers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 615 traditional Medicare patients, billed 4,637 HCPCS/CPT codes, and received $323,408 in Medicare payments. The top billing code was 90677 (Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use). Part D data shows 6,757 prescription claims across 710 beneficiaries totaling $735,222 in drug costs, led by Eliquis (Apixaban). DME data shows 153 claims. Open Payments data shows 21 records totaling $361. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $13,710 to $12,462.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	561	5,410	$319,544
2016	551	4,553	$289,281
2017	556	3,640	$222,879
2018	553	4,514	$306,660
2019	494	3,962	$263,288
2020	489	3,337	$235,513
2021	525	3,376	$276,943
2022	564	3,215	$274,280
2023	598	3,425	$307,244
2024	615	4,637	$323,408

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	418	6,438	$537,058
2016	456	6,275	$462,785
2017	502	7,428	$553,352
2018	527	8,039	$635,877
2019	535	6,649	$497,241
2020	530	6,521	$570,590
2021	554	5,768	$523,978
2022	590	6,610	$621,439
2023	610	6,815	$688,015
2024	710	6,757	$735,222

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	69	254	$5,897
2016	57	406	$18,610
2017	54	402	$29,820
2018	14	430	$19,184
2019	49	258	$10,109
2020	44	204	$9,955
2021	110	324	$23,324
2022	48	205	$12,758
2023	N/R	140	$5,728
2024	11	153	$7,325

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90677	Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use	157	157	$288
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	251	251	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	394	693	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	165	266	$69
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	174	185	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	214	4,995	$102,042
Ozempic	Semaglutide	80	3,292	$99,330
Trulicity	Dulaglutide	65	3,008	$95,577
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	1,800	$36,534
Jardiance	Empagliflozin	35	1,740	$33,073

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$2,272
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	23	$1,423
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	42	$1,231
A7030	Full face mask used with positive airway pressure device, each	N	N/R	11	$794
A7031	Face mask interface, replacement for full face mask, each	N	N/R	11	$610

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$361	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Keri Lynn Ingrassia-Squiers, DO?

Tedicare shows public-source Medicare data for Keri Lynn Ingrassia-Squiers, DO (NPI 1467465203), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Keri Lynn Ingrassia-Squiers, DO have ACO affiliation data?

Keri Lynn Ingrassia-Squiers, DO is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026).

What billing organization is linked to Keri Lynn Ingrassia-Squiers, DO?

Keri Lynn Ingrassia-Squiers, DO is linked to PRIMARY CARE PARTNERS LLC (billing NPI 1083900526) in the available physician profile data.

Does Keri Lynn Ingrassia-Squiers, DO have Open Payments data?

Keri Lynn Ingrassia-Squiers, DO has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.